2025-05-24 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc. (ISRG) based on the data you provided.

**Intuitive Surgical Inc. (ISRG) Analysis**

**Company Overview:** Intuitive Surgical Inc. is a company that designs, manufactures, and markets robotic surgical systems and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **ISRG Cumulative Return:** 131.81%
*   **VOO (S&P 500) Cumulative Return:** 79.45%
*   **Return Spread:** 52.4%
*   **Relative Spread Position:** 46.1 (This indicates ISRG's outperformance is positioned in the 46.1 percentile range based on historical data, not necessarily superior to VOO)

**Analysis:** ISRG has significantly outperformed the S&P 500 (VOO) over the period. However, the Relative Spread Position of 46.1 suggests that the current level of outperformance is not exceptionally high compared to its historical range.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
| ---------- | ------ | ----- | ----- | ---- | ------ |
| 2015-2017  | 68.0%  | 56.5% | 38.0% | 0.0  | 43.6   |
| 2016-2018  | 77.0%  | 63.4% | 60.0% | 0.0  | 57.2   |
| 2017-2019  | 81.0%  | 63.4% | 52.0% | 0.3  | 70.6   |
| 2018-2020  | 47.0%  | 63.4% | 22.0% | 0.2  | 97.7   |
| 2019-2021  | 91.0%  | 63.0% | 37.0% | 0.3  | 128.8  |
| 2020-2022  | -3.0%  | 69.9% | -9.0% | 0.3  | 95.1   |
| 2021-2023  | -5.0%  | 72.9% | -22.0% | 1.0  | 120.9  |
| 2022-2024  | 26.0%  | 72.9% | 9.0%  | 1.0  | 187.1  |
| 2023-2025  | 53.0%  | 72.9% | 25.0% | 0.7  | 193.4  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate has varied significantly over different periods, showing high growth periods (e.g., 2019-2021) and periods of negative growth (e.g., 2020-2023).
*   **MDD:** The Maximum Drawdown indicates significant volatility, with MDD consistently high across all periods.
*   **Alpha:**  Alpha has been positive during high-growth periods, indicating outperformance relative to the benchmark.  Negative Alpha values in more recent periods suggest underperformance.
*   **Beta:** Beta values are relatively low, suggesting ISRG's price is not highly correlated with the broader market (S&P 500). Beta increased in the most recent years to 1.0, meaning ISRG moves more in line with the market.
*   **Cap(B):** Market capitalization has grown significantly throughout the years.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 539.54
*   **Previous Close:** 542.67
*   **Change:** -0.58
*   **5-day Moving Average:** 549.61
*   **20-day Moving Average:** 541.38
*   **60-day Moving Average:** 514.07

**Analysis:**

*   The stock price is slightly down from the previous close.
*   The 5-day moving average is above the 20-day moving average, but both are trending lower.  The 20-day moving average is above the 60-day moving average. This suggests a possible short-term downward trend but a longer-term uptrend.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3656 (Low Risk)
*   **RSI:** 55.27 (Neutral)
*   **PPO:** -0.34 (Bearish)
*   **20-day Relative Spread Change:** -5.1 (Short-term decrease in relative performance)
*   **Expected Return:** 44.6% (Long-term, vs. S&P 500)

**Analysis:**

*   The Market Risk Indicator suggests a low level of market risk.
*   The RSI is neutral, indicating neither overbought nor oversold conditions.
*   The PPO is slightly negative, suggesting a potential bearish trend.
*   The decrease in the 20-day relative spread suggests a recent weakening in ISRG's performance compared to the S&P 500.
*   The high Expected Return (44.6%) suggests strong potential for long-term outperformance if investing at this time. The {'price': 539.54, 'previousClose': 542.67, 'change': -0.58} isn't a big issue, but should still be monitored.

**4. Recent News & Significant Events**

*   **Recent Volatility:** ISRG's stock has shown notable volatility.
*   **Analyst Discussions:** Analysts are discussing ISRG's recent performance and outlook.
*   **Business Developments/Regulatory Changes/Market Events:** ISRG has been in the news due to major business developments, regulatory changes, or market events.
*   **Risk/Opportunity Balance:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news points to increased attention on ISRG, likely due to recent performance and/or company-specific events. The advice to monitor news and company announcements is warranted.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출    |
| ---------- | ---- | ------- |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2025-04-23 | 1.54 | 1.89 B$ |

**Analysis:**

*   EPS and Revenue generally trended upwards in the recent quarters
*   Revenue is not repeating itself, despite the same date for 2025-04-23 and 2024-04-19, meaning the company is growing
*   EPS is higher on 2025-04-23 ($1.95) than 2024-04-19($1.54), meaning the company is becoming more profitable

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
| ---------- | -------- | ------------- |
| 2025-03-31 | $2.25B  | 64.69%        |
| 2024-12-31 | $2.41B  | 68.04%        |
| 2024-09-30 | $2.04B  | 67.41%        |
| 2024-06-30 | $2.01B  | 68.30%        |
| 2024-03-31 | $1.89B  | 65.87%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
| ---------- | --------- | ------- |
| 2025-03-31 | $17.11B  | 4.08%   |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |
| 2024-03-31 | $13.96B  | 3.90%   |

**Analysis:**

*   **Revenue:**  Revenue shows a generally increasing trend, with some quarter-to-quarter fluctuations.
*   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.
*   **Equity:** Equity is steadily increasing, reflecting growth in the company's net assets.
*   **ROE:** Return on Equity is stable, suggesting consistent profitability relative to equity.

**7. Overall Analysis**

Intuitive Surgical (ISRG) presents a mixed picture.

*   **Strengths:** Strong historical outperformance vs. the S&P 500, high profit margins, increasing revenue and equity, and a promising expected long-term return.
*   **Weaknesses/Concerns:** High maximum drawdown, recent underperformance compared to the S&P 500 (as indicated by the declining relative spread), recent stock price volatility, and the need to closely monitor news and company announcements. The high MDD needs to be considered, since this is a consistent issue.
*   **Overall:** While ISRG exhibits solid fundamentals and growth potential, investors should be aware of the volatility and recent performance dips. The long-term expected return remains attractive, but careful monitoring of market conditions and company news is crucial.

In summary, ISRG appears to be a company with strong long-term potential but also with notable risks. A buy-and-hold strategy with careful monitoring would be a reasonable approach.
